lu 135252 has been researched along with hydrochlorothiazide in 1 studies
Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) | Studies (hydrochlorothiazide) | Trials (hydrochlorothiazide) | Recent Studies (post-2010) (hydrochlorothiazide) |
---|---|---|---|---|---|
196 | 13 | 14 | 6,921 | 2,165 | 1,262 |
Protein | Taxonomy | lu 135252 (IC50) | hydrochlorothiazide (IC50) |
---|---|---|---|
Carbonic anhydrase 2 | Homo sapiens (human) | 5.4954 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dao, HH; De Champlain, J; Essalihi, R; Graillon, JF; Larivière, R; Moreau, P | 1 |
1 other study(ies) available for lu 135252 and hydrochlorothiazide
Article | Year |
---|---|
Pharmacological prevention and regression of arterial remodeling in a rat model of isolated systolic hypertension.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Arteries; Biphenyl Compounds; Calcinosis; Collagen; Disease Models, Animal; Elastin; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Cerebral Artery; Phenylpropionates; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 2002 |